• FOLLOW US
Video Player
  • Email
  • share

Jim Cramer Says Buy Celgene on Weakness Over Revlimid

TheStreet's Jim Cramer says Celgene (CELG), which ended Friday's session down more than 4-percent, is a great buy because the drugmaker is led by a great CEO. Cramer says Celgene CEO Robert Hugin has done a great job of diversifying the company's dru

http://www.11alive.com/video/3340981661001/1/Jim-Cramer-Says-Buy-Celgene-on-Weakness-Over-Revlimid http://cdn.newslook.com/46/460340c345701b9cbcb49e09b3d3d09b/images/frame_ext.jpg Jim Cramer Says Buy Celgene on Weakness Over Revlimid TheStreet's Jim Cramer says Celgene (CELG), which ended Friday's session down more than 4-percent, is a great buy because the drugmaker is led by a great CEO. Cramer says Celgene CEO Robert Hugin has done a great job of diversifying the company's dru jim cramerFinanceyoutubeYahoo!newslookCelgeneUnited Kingdom 01:10

Next Up

    

More Videos

Recent Videos

Page 1 of 7
Trailer: Home

Trailer: 'Home'

02:24 | 3/28/2015 5:47:38 AM
Trailer: Get Hard

Trailer: 'Get Hard'

02:23 | 3/28/2015 5:47:20 AM
Trailer: While Were Young

Trailer: 'While We're Young'

02:25 | 3/28/2015 5:47:02 AM
USA TODAY threepeat: Sky High

USA TODAY threepeat: Sky High

01:20 | 3/28/2015 3:52:47 AM
Raw: Amanda Knox grateful for sagas end

Raw: Amanda Knox grateful for saga's end

01:27 | 3/27/2015 11:27:13 PM